After Roe, Bayer Engages Lobbyists For Contraception Access

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push of its own.

A disclosure form reveals that Bayer has hired a team of lobbyists to advocate access to contraceptives in the United States as a result of the Supreme Court’s decision to overturn Roe v. Wade. Williams & Jensen was recruited by the company to focus on problems connected to contraceptives as well as prescription costs, Medicare coverage rules, and other things.

According to Politico, which used Bayer’s own analysis of disclosure forms going back to 1999, this is the first time the company has engaged lobbyists to promote access to contraceptives.

With Mirena, Skyla, and Kyleena, Bayer produces three of the most well-liked intrauterine devices (IUDs).

Since the U.S. Supreme Court’s decision to overturn Roe v. Wade in June, which raised concerns about birth control access nationwide, birth control and access to contraception have received considerable attention.

The Senate Republicans vetoed legislation that the House had passed last month that would have regulated the right to obtain contraception. The Biden administration responded by publishing instructions, advising health insurers that they must provide free coverage for all FDA-approved birth control methods under federal law.

Regarding Bayer, its advocacy work continues a trend that supports access to contraceptives. In order to ensure that 100 million women and girls in low- and middle-income nations have contraceptive access by 2030, the company promised $464 million in pledges last October to increase manufacturing capacity.

In Costa Rica, the business intends to build a state-of-the-art facility that will concentrate on long-acting reversible contraception, a popular technique of birth control that includes IUDs and contraceptive implants. The factory should be operational by 2024, according to the company.

And in June of last year, the business aimed to increase the production of contraceptives in Turku, Finland, the contraceptive capital of the world. The company invested $303 million at the time in a new manufacturing facility there.

Latest stories

Related stories

PDUFA Crucial for Biopharmaceutical Innovation in the US

The United States happens to lead the world when...

Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare

The 4th Annual "Internet + Pharma" Service Innovation Conference,...

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back